GRP
RYTM icon

Global Retirement Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

Global Retirement Partners’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$91.7K Buy
857
+457
+114% +$48.5K ﹤0.01% 1964
2025
Q3 		$40.4K Hold
400
– – ﹤0.01% 2024
2025
Q2 		$25.3K Buy
+400
New +$24.5K ﹤0.01% 2155
2024
Q4 		– Sell
-35
Closed -$1.83K – 3765
2024
Q3 		$1.83K Hold
35
– – ﹤0.01% 2966
2024
Q2 		$1.44K Hold
35
– – ﹤0.01% 3068
2024
Q1 		$1.52K Hold
35
– – ﹤0.01% 2847
2023
Q4 		$1.42K Buy
35
+7
+25% +$221 ﹤0.01% 2791
2023
Q3 		$599 Buy
+28
New +$627 ﹤0.01% 2908

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Global Retirement Partners's RYTM Position: Q4 2025 in Review

Global Retirement Partners increased its Rhythm Pharmaceuticals (RYTM) stake by 114% in Q4 2025, buying an estimated $48.5K and bringing the position to 857 shares worth $91.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1964.

Global Retirement Partners first reported a position in RYTM in Q3 2023 and has held it in 8 quarters since. 279 funds tracked by Wall St. Rank hold RYTM as of Q4 2025.

  • Global Retirement Partners held 857 shares of Rhythm Pharmaceuticals worth $91.7K as of Q4 2025.
  • Global Retirement Partners bought 457 Rhythm Pharmaceuticals shares in Q4 2025, an estimated $48.5K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #1964 holding.
  • Global Retirement Partners first reported a position in Rhythm Pharmaceuticals in Q3 2023 and has held it in 8 quarters since.
  • 279 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.